UChicago Medicine AdventHealth Cancer Institute Hinsdale is a clinical research site located in Hinsdale, Illinois, United States 60521.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
UChicago Medicine AdventHealth Cancer Institute Hinsdale has participated in 12 clinical trials with 9 currently active.
Therapeutic areas: Metastatic BRCA Hereditary Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UChicago Medicine AdventHealth Cancer Institute Hinsdale has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UChicago Medicine AdventHealth Cancer Institute Hinsdale has 12 clinical trials on record, with 9 currently active. Their work covers Metastatic BRCA Hereditary Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain.
Yes — UChicago Medicine AdventHealth Cancer Institute Hinsdale holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.